Table 3.
Prevalence of cardiovascular risk factors in the obesity-related hypertensive and non-obesity-related hypertensive patients.
| Variable | Overall | Non-obesity-related hypertension (N = 3673) | Obesity-related hypertension (N = 2410) | P † | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Overall | Men (N = 1623) | Women (N = 2050) | P* | Overall | Men (N = 742) | Women (N = 1668) | P* | |||
| Hypertriglyceridemia | 2207(36.3) | 1041(28.3) | 494(30.4) | 547(26.7) | 0.012 | 1166(48.4) | 352(47.4) | 814(48.8) | 0.537 | <0.001 |
| Hypercholesteremia | 788(13.0) | 469(12.8) | 154(9.5) | 315(15.4) | <0.001 | 319(13.2) | 59(8.0) | 260(15.6) | <0.001 | 0.595 |
| High low-density lipoprotein cholesterolemia | 756(12.4) | 427(11.6) | 142(8.7) | 285(13.9) | <0.001 | 329(13.7) | 90(12.1) | 239(14.3) | 0.147 | 0.019 |
| Diabetes mellitus | 1635(26.9) | 808(22.0) | 362(22.3) | 446(21.8) | 0.690 | 827(34.3) | 228(30.7) | 599(35.9) | 0.013 | <0.001 |
| Hyperuricemia | 799(13.1) | 347(9.4) | 217(13.4) | 130(6.3) | <0.001 | 452(18.8) | 200(26.9) | 252(15.1) | 0.022 | <0.001 |
Values are presented as number (%).
*p for comparison between men and women within either obesity-related hypertension or non-obesity-related hypertension.
†p for comparison overall obesity-related hypertensive patients and non-obesity-related hypertensive patients.